Blog

17 Articles

microscope on a blue background
Research
December 29, 2021 • 8 Min

Pancreatic Cancer Science—2021 in Review

As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.

pancreatic cancer patient Francois
Survivor Stories
November 12, 2021 • 6 Min

Taking Life with Pancreatic Cancer One Day at a Time

François has been taking chemotherapy for his pancreatic cancer treatment and living one day at a time, to make the most of his life.

abstract DNA image in bright greens and reds
Research
May 25, 2021 • 2 Min

PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations

A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.

pancreatic cancer patient Gina Harrison and her grandsons
Survivor Stories
August 18, 2020 • 4 Min

The Value of Molecular Profiling and Genetic Testing

Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.

DNA aqua pipette
Research
February 26, 2020 • 6 Min

Exploiting DNA Mutations For Pancreatic Cancer Treatment

Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.

Gloria Peterson, Ph.D.
Research
February 4, 2019 • 5 Min

Genetic Testing for All Pancreatic Cancer Patients

A study by Dr. Gloria Petersen’s research team has led to an official recommendation that all pancreatic cancer patients get genetic testing.

Old medicine bottles
Research
January 22, 2019 • 4 Min

A PARP Inhibitor Approval for Pancreatic Cancer

PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.

Dr. Allyson Ocean
Research
January 9, 2019 • 6 Min

Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019

Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.

Dr. Sapna Syngal
Research
November 14, 2018 • 4 Min

New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients

Dr. Sapna Syngal discusses the new NCCN guidelines, which support genetic testing for all pancreatic cancer patients, because mutations can influence treatment.

Kim Reiss Binder
Research
November 1, 2018 • 5 Min

PARP Inhibitors for Pancreatic Cancer Maintenance Treatment

Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.

Dr. Aimee Lucas
Research
October 19, 2018 • 4 Min

Which Is the Best Screening Method for Pancreatic Cancer?

Dr. Aimee Lucas outlines the pros and cons of various screening methods that can be used for pancreatic cancer, and who should be using them.

Marisa Harris
Survivor Stories
April 13, 2018 • 8 Min

Reimagining the Possible to Survive Stage IV Pancreatic Cancer

Marisa Harris was given a devastating diagnosis of stage IV pancreatic cancer. She tapped the power within herself, as well as chemotherapy, to become a long-term survivor.

Gloria Peterson, Ph.D.
Research
October 12, 2017 • 5 Min

Tumor Genetics Research Brings Some Answers for Families at High Risk

Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.

pancreatic cancer survivor Sharon Simone
Survivor Stories
March 28, 2017 • 4 Min

Tailoring My Treatment to My Tumor Genetics

After diagnosis with pancreatic cancer, Sharon Simone had her tumor analyzed. The report on her tumor genetics determined her treatment.

Illustration of the twisting spirals of two DNA double helices in royal blue and purple on a turquoise colored background
Research
October 18, 2016 • 2 Min

A New Drug Combination to Control Advanced Pancreatic Cancer

A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.

  • 1
  • 2